WebFeb 2, 2024 · Shares of gene-editing company Editas Medicine ( EDIT 1.02%) rose by a healthy 11.5% over the course of January, according to data provided by S&P Global … WebMay 11, 2024 · Demain, et grâce à l’impressionnant arraisonnement accompli au sein du groupe Lagardère, il s’étendra à Europe 1, au Journal du dimanche, à Paris-Match, et au groupe Hachette (Grasset, Stock, Le Livre de proche, Calmann-Lévy, JC Lattès, Larousse, Hatier, Fayard, etc.). – tout en se délestant alors d’Editis (décision annoncée ...
Vivendi venderà la rivista di celebrità Gala per ottenere l ...
WebEditas Medicine (NASDAQ: EDIT) and Bluebird Bio (NASDAQ: BLUE) are both beaten-down gene-editing stocks. Editas' shares are down by 65% in the last 12 months, … WebApr 11, 2024 · Le mois dernier, Vivendi a déclaré qu'il était en pourparlers pour vendre sa division d'édition Editis au milliardaire Daniel Kretinsky afin d'apaiser les inquiétudes de l'UE en matière d ... hairkiller lohr am main
Editas Medicine, Inc. (EDIT) Stock Historical Prices & Data
WebApr 10, 2024 · Editas Medicine Inc Stock Price History. Editas Medicine Inc’s price is currently down 8.55% so far this month. During the month of April, Editas Medicine Inc’s stock price has reached a high of $7.21 and a low of $6.45. Over the last year, Editas Medicine Inc has hit prices as high as $20.04 and as low as $6.70. Year to date, Editas ... WebApr 13, 2024 · The stock has traded between $6.36 and $7.64 so far today. Volume today is elevated. So far 2,503,752 shares have traded compared to average volume of 1,599,004 shares. To screen for more stocks like Editas Medicine Inc click here. More About Editas Medicine Inc Editas Medicine Inc is a genome editing company. WebApr 14, 2024 · Editas Medicine (. EDIT Quick Quote. EDIT - Free Report) shares soared 20.3% in the last trading session to close at $7.65. The move was backed by solid volume with far more shares changing hands ... pinto jail